AstraZeneca

British-Swedish pharmaceutical company

AstraZeneca ▸ Facts ▸ Comments ▸ News ▸ Videos

AstraZeneca plc is a British-Swedish multinational pharmaceutical and biopharmaceutical company with its headquarters in Cambridge, England. AstraZeneca has a portfolio of products for major disease areas including cancer, cardiovascular, gastrointestinal, infection, respiratory and inflammation. AstraZeneca AB, the Swedish arm of the company, is a subsidiary of AstraZeneca plc.

1 shares	Share Tweet Save Post Send


Covid vaccinations start at Boots branch in Halifax 82-year-old Victoria Watling became the first person to receive the coronavirus vaccine at the Boots pharmacy in Halifax. Boots and Superdrug branches are among the six stores across England which.. Credit: ODN Duration: 01:25Published 1 day ago


COVID vaccine: From factory to arm, the logistics of rolling out the Oxford-AstraZeneca jab The pace of the UK's vaccine rollout was ramped up this week with the opening of seven new mass vaccination centres Credit: Euronews English Duration: 02:33Published 2 days ago

Joan Collins gets COVID-19 vaccine and urges others to do the same Joan Collins just received the Oxford-AstraZeneca vaccine, and has urged others to do the same, as she says it was ‘the easiest thing’. Credit: Cover Video STUDIO Duration: 00:42Published 3 days ago

Explained: India announces Covid vaccination launch date; who's first in line? The Government of India announced the launch date of its mass immunisation programme against Covid-19. The vaccinations will begin on January 16, 2021. On January 3, India's drug regulator DCGI had.. Credit: HT Digital Content Duration: 01:34Published 6 days ago

UK approves Moderna Covid-19 vaccine The Moderna coronavirus vaccine has been approved for use in the UK. The jabis the third to be given the green light by the Medicines and Healthcareproducts Regulatory Agency (MHRA), along with the.. Credit: PA - Press Association STUDIO Duration: 00:59Published 1 week ago

COVID-19 Vaccines Are Making Their Way Around The World Mass vaccination campaigns are being rolled out around the globe. Governments around the world are looking for ways to contain the spread of COVID-19. Pfizer-BioNTech, Oxford-AstraZeneca, Sputnik V,.. Credit: Wochit News Duration: 00:39Published 1 week ago

100-year-old Ellen Prosser among first care home residents to receive Oxford vaccine 100 year-old Ellen Prosser is one of the first care home residents to recievethe Oxford/AstraZeneca vaccine at Sunrise care home in Sidcup. Dr Nikki Kananicarried out the first doses of the.. Credit: PA - Press Association STUDIO Duration: 00:40Published 1 week ago

GP nurse receives Oxford-AstraZeneca vaccine at surgery Nurse Sue Toye, 51, is believed to be the first person to receive the Oxford-AstraZeneca Covid-19 vaccine in a GP practice in England having had the jab atPriory Gate Surgery in the City of Coventry.. Credit: PA - Press Association STUDIO Duration: 00:46Published 1 week ago

Matt Hancock calls on Donald Trump to condemn violent scenes at US Capitol Health Secretary Matt Hancock calls on US President Donald Trump to condemnthe action of his supporters following violent scenes in Washington DC. MrHancock's comments came during a visit to see the.. Credit: PA - Press Association STUDIO Duration: 00:58Published 1 week ago

Covid: What led to DCGI nod of Covishield & Covaxin in India? IMCR DG explains ICMR DG Dr. Balram Bhargava explained the DCGI nod to two Covid-19 vaccines in India. Dr. Bhargava spoke on the various studies done over Covishield and Covaxin. Covishield Oxford-AstraZeneca vaccine.. Credit: HT Digital Content Duration: 04:32Published 1 week ago

'Who will opt for vaccine...': Congress questions approval, slams govt Congress leader Manish Tewari alleged that the union government has 'politically misused pandemic in its entirety'. Tewari also slammed the Centre over the grant of approval to Bharat Biotech's Covid.. Credit: HT Digital Content Duration: 03:25Published 1 week ago

Rollout of Oxford Covid-19 vaccine begins in Scotland The first doses of the Oxford University and AstraZeneca vaccine have beenadministered in Scotland. James Shaw, 82, from Dundee, was among the first toget the jab.The UK has secured access to 100.. Credit: PA - Press Association STUDIO Duration: 00:46Published 2 weeks ago

UK is first country in the world to rollout Oxford-AstraZeneca vaccine It comes as COVID-19 cases, driven by a new variant, are surging. Credit: euronews (in English) Duration: 00:50Published 2 weeks ago

I feel privileged to have given first vaccine, says nurse Sam Foster says she feels "privileged" to have administered the first Oxford-AstraZeneca vaccine. The Chief Nurse at Oxford University Hospitals delivered the vaccine to Brian Pinker, an 82-year-old.. Credit: ODN Duration: 00:40Published 2 weeks ago

'I'm from farmer family...': Vaccine-maker Bharat Biotech's MD on controversy Chairman and Managing Director of Bharat Biotech, Dr Krishna Ella, addressed a virtual conference amid doubts from some quarters regarding approval of the vaccine developed by the Indian company. On.. Credit: HT Digital Content Duration: 08:59Published 2 weeks ago

Pensioner receives Oxford jab in Belfast Eileen Lynch, 94, gave the thumbs up after becoming one of the first people inNorthern Ireland to receive the Oxford/AstraZeneca coronavirus vaccine. It wasdelivered at a GP surgery on the Falls Road.. Credit: PA - Press Association STUDIO Duration: 01:18Published 2 weeks ago

UK inoculates first patient with Oxford/AstraZeneca COVID-19 vaccine The UK began distributing the Oxford/AstraZeneca COVID-19 vaccine on Monday after becoming the first country to authorise it. Credit: Euronews English Duration: 01:37Published 2 weeks ago

COVAXIN has shown less than 10% adverse reactions: Bharat Biotech MD While addressing a press conference via video conferencing in Hyderabad on January 04, the Chairman and Managing Director (MD) of Bharat Biotech International Limited, Dr Krishna M Ella said, "COVAXIN.. Credit: ANI Duration: 01:42Published 2 weeks ago

Britain's Johnson visits hospital as Oxford vaccine rollout begins Britain began vaccinating its population with Oxford University and AstraZeneca's COVID-19 shot on Monday in a world first, racing to give protection to the elderly and vulnerable as a new surge of.. Credit: Reuters Studio Duration: 01:06Published 2 weeks ago

'Gamechanger' to have Oxford-AstraZeneca says Powis Professor Stephen Powis has said the rollout of the Oxford-AstraZeneca vaccine is a "gamechanger" during a "very concerning time" in the pandemic. The National Medical Director of NHS England added.. Credit: ODN Duration: 01:51Published 2 weeks ago

First Oxford vaccine dose administered in UK The first dose of the Oxford-AstraZeneca vaccine has been administered in the UK. Brian Pinker, 82, became the first person in the world to receive the jab at the Churchill Hospital in Oxford since it.. Credit: ODN Duration: 01:26Published 2 weeks ago

Tougher action needed to curb coronavirus spread says PM Boris Johnson has warned of "tough, tough" weeks to come as the Government came under pressure to announce another national lockdown amid concerns the new coronavirus variant is spreading out of.. Credit: ODN Duration: 01:48Published 2 weeks ago

You Might Like

Serum Institute expects WHO emergency approval for AstraZeneca shot soon The Serum Institute of India expects WHO emergency-use authorization soon for the Oxford University/AstraZeneca coronavirus vaccine, which it is producing for mid and low income countries, its chief.. IndiaTimes - Published 1 day ago
AstraZeneca 'on track' to deliver two million doses a week - as it calls for priority access AstraZeneca says it expects to release two million doses of the Oxford vaccine every week by mid-February - and has asked for its workers to get priority access to avoid COVID outbreaks hindering.. Sky News - Published 2 days ago
Covid vaccine recipients may not be able to pick & choose Even as the government plans to roll out the Covid vaccination drive with Oxford-AstraZeneca’s Covishield and Bharat Biotech’s Covaxin, recipients may not have an option to choose which one they.. IndiaTimes - Published 3 days ago

SII gets order for 11 million vaccine doses, trucks ready for transportation The process of transporting Covishield vaccine began on Monday after the Serum Institute of India (SII) received the Centre’s initial purchase order for 11 million doses at Rs 200 per dose. This.. IndiaTimes - Published 4 days ago
India wants Serum Institute to lower price of AstraZeneca shot, say sources The Indian government has been negotiating with the Serum Institute of India to bring down the price of AstraZeneca's Covid-19 vaccine, delaying the roll-out of the country's immunisation programme... IndiaTimes - Published 4 days ago
Brazil's Bolsonaro asks India to expedite Covid vaccine shipment as delays loom Brazilian President Jair Bolsonaro asked Prime Minister Narendra Modi to expedite a shipment of AstraZeneca's Covid-19 vaccine amid broader delays to the vaccine's arrival in Brazil, according to a.. IndiaTimes - Published 1 week ago

Surgery visited by Hancock to mark Oxford/AstraZeneca jab rollout has delivery of it delayed The GP surgery visited by the health secretary to mark the expanded rollout of the Oxford/AstraZeneca coronavirus vaccine has not yet received any of it. Sky News - Published 1 week ago
COVID-19: GPs join biggest vaccination programme in NHS history GP surgeries in England are to begin rolling out the Oxford/AstraZeneca coronavirus jab as part of the biggest vaccination programme in NHS history. Sky News - Published 1 week ago
All-India vaccine rollout set for next week: Govt The government will roll out the Covid-19 vaccine next week, with health secretary Rajesh Bhushan saying this was set to happen within 10 days of emergency use authorisation being granted. The Indian.. IndiaTimes - Published 1 week ago
All Indian vaccines being developed for storage at 2-8 degree Celsius: DBT secretary Swarup said Dr Reddy's Laboratories has partnered with Russia's Gamaleya Institute and a vaccine is being developed for India targeting storage at 2-8 degrees Celsius. The country's drugs regulator.. IndiaTimes - Published 1 week ago

82-year-old man first to receive Oxford-AstraZeneca vaccine in UK An 82-year-old man has become the first person in the UK to receive the Oxford-AstraZeneca vaccine since it was approved for use. Sky News - Published 2 weeks ago
'Pivotal moment': First doses of Oxford University-AstraZeneca vaccine to be given today The first doses of the Oxford University-AstraZeneca vaccine will be administered in the UK today in what the government has described as a "pivotal moment" in the fight against coronavirus. Sky News - Published 2 weeks ago
Serum Institute says to meet local demand for AstraZeneca vaccine for next two months before exporting Serum Institute of India (SII), the local maker of the AstraZeneca/Oxford coronavirus vaccine, said on Sunday it intends to concentrate on meeting India's own immediate demand in the next two months.. IndiaTimes - Published 2 weeks ago	Bharat Biotech’s Covaxin too gets nod for emergency use India's vaccine rollout will begin with the availability of two jabs- Oxford-Astra Zeneca's Covishield and Bharat Biotech's homegrown Covaxin- with the Drugs Controller General of India expected to.. IndiaTimes - Published 2 weeks ago
Son of oldest NHS doctor to die with COVID calls for health workers to get vaccine first The son of the oldest NHS frontline doctor to die after contracting COVID-19 says health and care workers should be the first to receive the Oxford/AstraZeneca coronavirus vaccine. Sky News - Published 2 weeks ago	Batches of Oxford/AstraZeneca vaccine arrive at UK hospitals ahead of nationwide roll-out Batches of the Oxford/AstraZeneca coronavirus vaccine have started arriving at UK hospitals ahead of the jab's nationwide roll-out. Sky News - Published 2 weeks ago
COVID-19: India gives nod to AstraZeneca's Covishield vaccine for mass immunisation It is the first COVID-19 vaccine to be approved for emergency use by India, which has the highest number of infections after the United States. DNA - Published 2 weeks ago	Happy New Year: Expert panel clears Oxford vaccine for India India moved closer to the rollout of its vaccination plan against Covid-19 with the subject expert committee of the drug regulator on Friday recommending emergency-use authorisation (EUA) for Serum.. IndiaTimes - Published 2 weeks ago
India set to approve its first Covid vaccine; nationwide dry run tomorrow A day ahead of the nationwide Covid-19 vaccination dry run, the Indian drug regulator's expert panel on Friday cleared the decks for emergency use authorisation for the vaccine developed by AstraZeneca.. IndiaTimes - Published 2 weeks ago	Oxford Covid vaccine set to become first to get approval in India: Report The expert panel is likely to approve the vaccine developed by AstraZeneca and Oxford University for emergency use on Friday, Reuters reported quoting sources. If approved, India will become the third.. IndiaTimes - Published 2 weeks ago
India's drug regulator to meet again on January 1 to discuss AstraZeneca vaccine CDSCO, India's drug regulator will meet on Friday to consider approving AstraZeneca and Oxford University's Covid-19 vaccine for emergency use. SII, the world's biggest vaccine producer, has already.. IndiaTimes - Published 2 weeks ago	UK approval of Oxford-AstraZeneca Covid-19 vaccine positive news, waiting for India's approval: Serum Institute IndiaTimes - Published 2 weeks ago
Covaxin can offer protection against mutated coronavirus: Bharat Biotech Vaccine makers like Pfizer and AstraZeneca have also said that their vaccines against Covid-19 should work against the new strain. DNA - Published 2 weeks ago	Covid-19: Oxford vaccine may get nod in a few days India is likely to see the Oxford-AstraZeneca vaccine being approved for emergency use in next few days as the updated data submitted by Serum Institute of India (SII) appears “satisfactory”, top.. IndiaTimes - Published 3 weeks ago
India likely to approve AstraZeneca vaccine by next week This could be the first country to give the regulatory green light for the British drugmaker’s vaccine as the British medicine regulator continues to examine data from the trials. The.. IndiaTimes - Published 3 weeks ago	Our vaccine can be effective against new coronavirus variant: AstraZeneca Drugmakers are scrambling to test their COVID-19 vaccines against the new fast-spreading variant of the virus that is raging in Britain. DNA - Published 3 weeks ago
India requires Rs 80,000 crore for vaccine distribution next year: SII NEW DELHI: Pune-based vaccine-maker Serum Institute of India, which has partnered with AstraZeneca to manufacture the Oxford-AstraZeneca vaccine, on Saturday said that the country would require a.. IndiaTimes - Published on December 19, 2020	Oxford-AstraZeneca's Covid vaccine can be available in India by 1st half of next year: Official IndiaTimes - Published on December 12, 2020
India readies for 60 crore COVID vaccine jabs; to use standard cold storage Indian regulators are considering 3 vaccines for emergency use authorisation, including those from Pfizer Inc, AstraZeneca and Bharat Biotech. DNA - Published on December 12, 2020	India speeding up review of Pfizer, Astra Covid-19 vaccines: Govt official India is accelerating its review of coronavirus vaccines developed by Pfizer Inc and AstraZeneca for emergency use, a senior government official said on Monday, as the world's second-most affected.. IndiaTimes - Published on December 7, 2020
Covid-19: India pins hopes on 4 vaccines to inoculate 30 crore by July The government is expecting two vaccines against Covid-19 — Oxford-AstraZeneca’s Covishield and Bharat Biotech’s Covaxin — to be available by January and around four vaccines by the end of.. IndiaTimes - Published on December 6, 2020	AstraZeneca to sell 2.5 billion shots to 17 countries Data shows that seven vaccine makers together have confirmed contracts to supply 6.2 billion doses of vaccines to a pool of around 20 countries, while another 12 vaccine makers together have deals for.. IndiaTimes - Published on December 3, 2020
AstraZeneca partner sticks with two full dose regimen in Covid trials in India The British drugmaker has said its Covid-19 vaccine could be up to 90% effective if administered as a half dose followed by a full dose, but some scientists have questioned the robustness of that.. IndiaTimes - Published on December 1, 2020	Serum says AstraZeneca's Covid-19 vaccine safe, no co-relation with side-effects Serum Institute of India, the world's largest vaccine manufacturer, on Tuesday denied allegations that a Covid-19 trial volunteer suffered serious side effects from a vaccine developed by AstraZeneca.. IndiaTimes - Published on December 1, 2020
India looking to be self-reliant in development, production of vaccine against Covid-19 While at least five pharmaceutical companies of India are engaged in vaccine development, Serum Institute in Pune has been chosen for mass production of Covishield vaccine developed by Oxford -Astra.. IndiaTimes - Published on November 30, 2020	Gujarat: PM Modi reviews vaccine development at Zydus Cadila facility Prime Minister Narendra Modi on Saturday began his three-city visit to review coronavirus vaccine development work by going to pharma major Zydus Cadila's manufacturing facility near Ahmedabad. After.. IndiaTimes - Published on November 28, 2020
Vaccine tour: PM Modi arrives at SII in Pune to review COVID-19 vaccine development The Serum Institute of India has partnered with global pharma giant AstraZeneca and Oxford University for the vaccine. DNA - Published on November 28, 2020	PM to visit vaccine centres in 3 cities While in Hyderabad, the PM will visit vaccine maker Bharat Biotech’s facilities, where work on the development of India’s first indigenous Covid-19 vaccine, Covaxin, is under way, he will drop in.. IndiaTimes - Published on November 26, 2020
India to consider clinical trials data of two full doses of AstraZeneca vaccine India will consider clinical trial data for the two full-dose Oxford-AstraZeneca Covid-19 vaccine candidate which the firm says has an efficacy of 62% and not the “half plus full” dose regime which.. IndiaTimes - Published on November 26, 2020	AstraZeneca-Oxford vaccine safe, Indian trials progressing smoothly: Serum Institute Vaccine major Serum Institute of India on Thursday said the Covid-19 vaccine developed by AstraZeneca and Oxford University is safe and effective, and the Indian trials are progressing smoothly with.. IndiaTimes - Published on November 26, 2020
AstraZeneca inks pact with Research Society for Study of Diabetes in India IndiaTimes - Published on November 26, 2020	Covid-19: PM Modi to visit Serum Institute of India in Pune on Nov 28 Prime Minister Narendra Modi will on Saturday visit the Pune-based Serum Institute of India, which has partnered with global pharma giant AstraZeneca and the Oxford University for Covid-19 vaccine, a.. IndiaTimes - Published on November 26, 2020Also reported by •DNA
AstraZeneca manufacturing error clouds vaccine study results In a surprise, the group of volunteers that got a lower dose seemed to be much better protected than the volunteers who got two full doses. In the low-dose group, AstraZeneca said, the vaccine appeared.. IndiaTimes - Published on November 26, 2020	Oxford vaccine ‘70% effective’, may get India nod by year-end Armed with interim findings of the AstraZeneca-Oxford Covid-19 vaccine trials — which showed 70% effectiveness in preventing people from getting infected — Pune-based Serum Institute of India (SII).. IndiaTimes - Published on November 23, 2020
After Pfizer and Moderna, Oxford-AstraZeneca claims 90% efficacy of COVID-19 vaccine According to the Oxford University release, no volunteer complained of any medical issue during the trial of the vaccine. DNA - Published on November 23, 2020	Covid-19: Govt may get Oxford shots in Jan-Feb, at 50% of MRP India is likely to get the first lot of anti-Covid shots in late January-early February. This will be possible as India plans to give Serum Institute of India emergency use approval for the.. IndiaTimes - Published on November 22, 2020
As race for vax nears last lap, Modi reviews India’s strategy Prime Minister Narendra Modi on Friday held a review of India’s vaccination strategy amid indications that the fast-developing Oxford-AstraZeneca shot may be eligible for emergency use authorisation.. IndiaTimes - Published on November 20, 2020	India could get access to AstraZeneca vaccine by January, says local manufacturer IndiaTimes - Published on November 20, 2020
Indians to get 'Covishield' vaccine for Rs 500-600, govt to get it at even lesser price 'Covishield', the frontrunner to India's race for Covid-19 vaccine, is manufactured by Serum Institute of India in agreement with Oxford-AstraZeneca. DNA - Published on November 20, 2020	India to get 100 million doses of Oxford COVID-19 vaccine by Dec, says Adar Poonawalla SII, which has tied up with five developers, has so far made 40 million doses of AstraZeneca vaccine in the past two months and aims to start manufacturing Novavax's contender soon. DNA - Published on November 14, 2020

AstraZeneca

British-Swedish pharmaceutical company

AstraZeneca ▸ Facts ▸ Comments ▸ News ▸ Videos

You Might Like

Serum Institute expects WHO emergency approval for AstraZeneca shot soon

AstraZeneca 'on track' to deliver two million doses a week - as it calls for priority access

Covid vaccine recipients may not be able to pick & choose

SII gets order for 11 million vaccine doses, trucks ready for transportation

India wants Serum Institute to lower price of AstraZeneca shot, say sources

Brazil's Bolsonaro asks India to expedite Covid vaccine shipment as delays loom

Surgery visited by Hancock to mark Oxford/AstraZeneca jab rollout has delivery of it delayed

COVID-19: GPs join biggest vaccination programme in NHS history

All-India vaccine rollout set for next week: Govt

All Indian vaccines being developed for storage at 2-8 degree Celsius: DBT secretary

82-year-old man first to receive Oxford-AstraZeneca vaccine in UK

'Pivotal moment': First doses of Oxford University-AstraZeneca vaccine to be given today

Serum Institute says to meet local demand for AstraZeneca vaccine for next two months before exporting

Bharat Biotech’s Covaxin too gets nod for emergency use

Son of oldest NHS doctor to die with COVID calls for health workers to get vaccine first

Batches of Oxford/AstraZeneca vaccine arrive at UK hospitals ahead of nationwide roll-out

COVID-19: India gives nod to AstraZeneca's Covishield vaccine for mass immunisation

Happy New Year: Expert panel clears Oxford vaccine for India

India set to approve its first Covid vaccine; nationwide dry run tomorrow

Oxford Covid vaccine set to become first to get approval in India: Report

India's drug regulator to meet again on January 1 to discuss AstraZeneca vaccine

UK approval of Oxford-AstraZeneca Covid-19 vaccine positive news, waiting for India's approval: Serum Institute

Covaxin can offer protection against mutated coronavirus: Bharat Biotech

Covid-19: Oxford vaccine may get nod in a few days

India likely to approve AstraZeneca vaccine by next week

Our vaccine can be effective against new coronavirus variant: AstraZeneca

India requires Rs 80,000 crore for vaccine distribution next year: SII

Oxford-AstraZeneca's Covid vaccine can be available in India by 1st half of next year: Official

India readies for 60 crore COVID vaccine jabs; to use standard cold storage

India speeding up review of Pfizer, Astra Covid-19 vaccines: Govt official

Covid-19: India pins hopes on 4 vaccines to inoculate 30 crore by July

AstraZeneca to sell 2.5 billion shots to 17 countries

AstraZeneca partner sticks with two full dose regimen in Covid trials in India

Serum says AstraZeneca's Covid-19 vaccine safe, no co-relation with side-effects

India looking to be self-reliant in development, production of vaccine against Covid-19

Gujarat: PM Modi reviews vaccine development at Zydus Cadila facility

Vaccine tour: PM Modi arrives at SII in Pune to review COVID-19 vaccine development

PM to visit vaccine centres in 3 cities

India to consider clinical trials data of two full doses of AstraZeneca vaccine

AstraZeneca-Oxford vaccine safe, Indian trials progressing smoothly: Serum Institute

AstraZeneca inks pact with Research Society for Study of Diabetes in India

Covid-19: PM Modi to visit Serum Institute of India in Pune on Nov 28

AstraZeneca manufacturing error clouds vaccine study results

Oxford vaccine ‘70% effective’, may get India nod by year-end

After Pfizer and Moderna, Oxford-AstraZeneca claims 90% efficacy of COVID-19 vaccine

Covid-19: Govt may get Oxford shots in Jan-Feb, at 50% of MRP

As race for vax nears last lap, Modi reviews India’s strategy

India could get access to AstraZeneca vaccine by January, says local manufacturer

Indians to get 'Covishield' vaccine for Rs 500-600, govt to get it at even lesser price

India to get 100 million doses of Oxford COVID-19 vaccine by Dec, says Adar Poonawalla